pharmacogenomics


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

phar·ma·co·ge·no·mics

 (fär′mə-kō-jə-nō′mĭks)
n. (used with a sing. verb)
The study of inherited variations in genetic factors that influence a patient's metabolic response to a given drug, especially adverse side effects. Also called pharmacogenetics.

pharmacogenomics

(ˌfɑːməkəʊdʒɪˈnɒmɪks)
n (functioning as singular)
1. (Medicine) the study of human genetic variability in relation to drug action and its application to medical treatment
2. (Genetics) the study of human genetic variability in relation to drug action and its application to medical treatment
ˌpharmacogeˈnomic adj
Mentioned in ?
References in periodicals archive ?
In addition, pharmacogenomics testing products aid physicians in individualizing and optimization of patient's therapeutic regimen.
Pharmacogenomics focuses on delivering the right medicine at the right dose based on a patient's genetic makeup.
To help bridge this knowledge gap, we list practical, freely available pharmacogenomics resources that a psychiatric practitioner can use.
Additional plans include a site for sharing case studies demonstrating the utility of pharmacogenomics in patient care, a site listing current publications relating to pharmacogenomics in patient care with direct links to the articles where possible.
The new financing follows the recent announcement regarding an enhancement to the GeneSight Psychotropic test, now the most comprehensive neuropsychiatric pharmacogenomics test available.
The agreement is believed to mark the first time a pharmacogenomics company has partnered with a pharmacy benefits manager (PBM) to assist in decision making by using genetic tests to determine whether patients have side effects or respond to particular drugs.
Other links lead to the Department of Energy's site on pharmacogenomics, the Pharmaceutical Research and Manufacturers of America's genomics resource guide, the Human Genetic Cell Repository, dbSNP (a database of single-nucleotide polymorphisms), the Protein Data Bank, and PharmGKB.
M2 PHARMA-May 9, 2014-Enable Healthcare to provide CompanionDx's pharmacogenomics testing to physician network
credits the guidance with removing regulatory uncertainty and encouraging broader adoption of pharmacogenomics in order to develop safer and more effective medicines.